Drug Type Gene therapy |
Synonyms p53 gene therapy (Introgen Therapeutics), INGN 234, P53 TOPICAL |
Target |
Action stimulants |
Mechanism p53 stimulants(Tumor protein p53 stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Phase 2 | United States | - | |
Leukoplakia | Phase 2 | United States | - | |
Vitiligo | Phase 2 | - | - | |
Vitiligo | Phase 2 | - | - | |
Vitiligo | Phase 2 | - | - |